Failure-free survival after initial systemic treatment of chronic graft-versus-host disease

This study was designed to characterize failure-free survival (FFS) as a novel end point for clinical trials of chronic graft-versus-host disease (GVHD). The study cohort included 400 consecutive patients who received initial systemic treatment of chronic GVHD at our center. FFS was defined by the a...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Inamoto, Yoshihiro, Flowers, Mary E. D., Sandmaier, Brenda M., Aki, Sahika Z., Carpenter, Paul A., Lee, Stephanie J., Storer, Barry E., Martin, Paul J.
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society of Hematology 2014
נושאים:
Transplantation
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4141518/
https://ncbi.nlm.nih.gov/pubmed/24876566
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2014-03-563544
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים